MAPT and Alzheimer disease: Purushothuman et al. demonstrated the beneficial effect of transcranial PBM (670 nm LEDs, 4 J/cm2, 20 min per session for 4 weeks) in two mouse models of AD, such as the K369I tau transgenic model and the APPswe/PSEN1dE9 transgenic model [70,71].